BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 24974205)

  • 1. Drug repositioning by integrating target information through a heterogeneous network model.
    Wang W; Yang S; Zhang X; Li J
    Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heter-LP: A Heterogeneous Label Propagation Method for Drug Repositioning.
    Lotfi Shahreza M; Ghadiri N; Green JR
    Methods Mol Biol; 2019; 1903():291-316. PubMed ID: 30547450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information.
    Luo Y; Zhao X; Zhou J; Yang J; Zhang Y; Kuang W; Peng J; Chen L; Zeng J
    Nat Commun; 2017 Sep; 8(1):573. PubMed ID: 28924171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HINGRL: predicting drug-disease associations with graph representation learning on heterogeneous information networks.
    Zhao BW; Hu L; You ZH; Wang L; Su XR
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
    Jarada TN; Rokne JG; Alhajj R
    BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures.
    Namba S; Iwata M; Yamanishi Y
    Bioinformatics; 2022 Jun; 38(Suppl 1):i68-i76. PubMed ID: 35758779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gene2drug: a computational tool for pathway-based rational drug repositioning.
    Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
    Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
    Zhao M; Yang CC
    J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Drug Repositioning Approach Based on Integrative Multiple Similarity Measures.
    Yan C; Feng L; Wang W; Wang J; Zhang G; Luo J
    Curr Mol Med; 2020; 20(6):442-451. PubMed ID: 31729291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network-based drug repurposing method via non-negative matrix factorization.
    Sadeghi S; Lu J; Ngom A
    Bioinformatics; 2022 Feb; 38(5):1369-1377. PubMed ID: 34875000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.
    Re M; Valentini G
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1359-71. PubMed ID: 24407295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.
    Li Y; Yang Y; Tong Z; Wang Y; Mi Q; Bai M; Liang G; Li B; Shu K
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEDD: a network embedding based method for predicting drug-disease associations.
    Zhou R; Lu Z; Luo H; Xiang J; Zeng M; Li M
    BMC Bioinformatics; 2020 Sep; 21(Suppl 13):387. PubMed ID: 32938396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing based on the DTD-GNN graph neural network: revealing the relationships among drugs, targets and diseases.
    Li W; Ma W; Yang M; Tang X
    BMC Genomics; 2024 Jun; 25(1):584. PubMed ID: 38862928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.